Min-Bin Chen
Overview
Explore the profile of Min-Bin Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
1456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu X, Zhu J, Gu Q, Liu N, Lu J, Li X, et al.
Cell Death Dis
. 2025 Feb;
16(1):114.
PMID: 39971925
The tumor microenvironment (TME) is pivotal in non-small cell lung cancer (NSCLC) progression, influencing drug resistance and immune cell behavior through complex ligand-receptor (LR) interactions. This study developed an epithelial...
2.
Liu N, Zhu X, Wu C, Liu Y, Chen M, Gu J
Cell Death Discov
. 2024 Nov;
10(1):478.
PMID: 39578429
Recently, changes in metabolites and metabolism-related enzymes related to tumor cell proliferation, metastasis, drug resistance, and immunosuppression have become a research hotspot, and researchers have attempted to determine the clinical...
3.
Peng S, Zhu X, Zhao M, Zhang Y, Wang A, Chen M, et al.
Cell Death Dis
. 2023 Feb;
14(2):157.
PMID: 36828810
Pancreatic cancer has an extremely poor prognosis. Here we examined expression, potential functions and underlying mechanisms of MXRA5 (matrix remodeling associated 5) in pancreatic cancer. Bioinformatics studies revealed that MXRA5...
4.
Zhu X, Zhu J, Chen Y, Liu Y, Lu J, Sun J, et al.
Front Oncol
. 2022 Aug;
12:972744.
PMID: 35982956
Background: Liver cancer is among the leading causes of death related to cancer around the world. The most frequent type of human liver cancer is hepatocellular carcinoma (HCC). Fatty acid...
5.
Zhou L, Feng C, Zhang Y, Li P, Tang M, Chen M, et al.
J Gastrointest Oncol
. 2022 Jul;
13(3):1086-1096.
PMID: 35837160
Background: The basic platelet counts of schistosomiasis patients are low. If it does not meet the requirements for chemotherapy, the patient's treatment will not be carried out, which directly affects...
6.
Zhang Y, Jin J, Tang M, Li P, Zhou L, Du Y, et al.
Biomed Res Int
. 2022 Jun;
2022:6743126.
PMID: 35707390
Purpose: Tumor mutational burden (TMB), microsatellite instability-high (MSI-H), and expression of programmed death ligand-1 (PD-L1) have emerged as predictive biomarkers for responsiveness to immune checkpoint inhibitors (ICIs) in several cancer...
7.
Yao J, Wu X, Yu Q, Yang S, Yuan J, Zhang Z, et al.
Sci Adv
. 2022 May;
8(21):eabn6928.
PMID: 35622925
We here examined the potential biological function of phosphoenolpyruvate carboxykinase 1 (PCK1) in angiogenesis. shRNA- or CRISPR-Cas9-induced PCK1 depletion potently inhibited endothelial cell proliferation, migration, sprouting, and tube formation, whereas...
8.
Zhang Y, Cheng L, Shi X, Song Y, Chen X, Chen M, et al.
Int J Biol Sci
. 2022 May;
18(7):2994-3005.
PMID: 35541904
Overexpression and/or overactivation of sphingosine kinase 1/2 (SphK1/2) is important for tumorigenesis and progression of cervical cancer. The current study examined the potential activity and signaling mechanisms of SKI-V, a...
9.
Lu J, Chen M, Gao X, Zhang Y, Liu Y, Yong Y, et al.
J Int Med Res
. 2022 Mar;
50(3):3000605221087050.
PMID: 35317622
In adults, embryonal rhabdomyosarcoma (ERMS) is rare and has a poor prognosis. Giant perianal ERMS with severe multiple bone metastases at initial diagnosis has not been reported and lacks effective...
10.
Bian Z, Shan H, Zhu Y, Shi C, Chen M, Huang Y, et al.
Int J Biol Sci
. 2022 Mar;
18(4):1508-1520.
PMID: 35280670
Sustained activation of multiple receptor tyrosine kinases (RTKs) simultaneously is vital for tumorigenesis and progression of osteosarcoma (OS). Gαi proteins recruitment to various RTKs mediates downstream oncogenic signaling activation. The...